GALNT6 promotes bladder cancer malignancy and immune escape by epithelial-mesenchymal transition and CD8+ T cells
Cancer Cell International,
Abstract Bladder cancer (BC) ranks as the sixth cancer in males and the ninth most common cancer worldwide.